About Ovagen
Ovagen is a company based in Ireland founded in 2000 by Leonard Moran.. Ovagen has raised $25.21 million across 8 funding rounds from investors including European Investment Bank, Enterprise Ireland and European Union. Ovagen operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and IDT Biologika, among others.
- Headquarter Mayo, Ireland
- Founders Leonard Moran
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.21 M (USD)
in 8 rounds
-
Latest Funding Round
$2.16 M (USD), Unspecified
Oct 29, 2024
-
Investors
European Investment Bank
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ovagen
Ovagen has successfully raised a total of $25.21M across 8 strategic funding rounds. The most recent funding activity was a Unspecified round of $2.16 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Unspecified — $2.2M
-
First Round
First Round
(01 Apr 2008)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Unspecified - Ovagen | Valuation | Western Development Commission | |
| Feb, 2023 | Amount | Unspecified - Ovagen | Valuation | Irrus Investments , West Coast, North West | |
| Jun, 2022 | Amount | Unspecified - Ovagen | Valuation | European Investment Bank |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ovagen
Ovagen has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity & debt fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A platform connecting angel investors to startups in Ireland.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ovagen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ovagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ovagen Comparisons
Competitors of Ovagen
Ovagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and IDT Biologika, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ovagen
Frequently Asked Questions about Ovagen
When was Ovagen founded?
Ovagen was founded in 2000 and raised its 1st funding round 8 years after it was founded.
Where is Ovagen located?
Ovagen is headquartered in Ireland. It is registered at Mayo, Ireland.
Who is the current CEO of Ovagen?
Leonard Moran is the current CEO of Ovagen. They have also founded this company.
Is Ovagen a funded company?
Ovagen is a funded company, having raised a total of $25.21M across 8 funding rounds to date. The company's 1st funding round was a Unspecified of $7.91M, raised on Apr 01, 2008.
What does Ovagen do?
Ovagen was founded in 2000 and is based in Mayo, Ireland. Operations focus on the biotechnology sector, where germ-free and specific pathogen-free eggs are produced for use in vaccine development and antibody manufacturing. Services include specialized egg production tailored to pharmaceutical needs, ensuring controlled environments free from contaminants. The company supports research and production activities in the immunology and biopharma industries across Europe.
Who are the top competitors of Ovagen?
Ovagen's top competitors include KBI Biopharma, Aldevron and Laurus Bio.
Who are Ovagen's investors?
Ovagen has 10 investors. Key investors include European Investment Bank, Enterprise Ireland, European Union, Western Development Commission, and Irrus Investments.